Development of Secondary Cancers in Pre- vs Post-ICI Eligibility Periods for Metastatic Cancers

This cohort study investigates incidence of secondary primary cancers before vs after approval of immune checkpoint inhibitors (ICIs) among patients with metastatic cancers.

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2026-02-04
DOI
https://doi.org/10.1001/jamanetworkopen.2025.57807
Primary Topic
Multiple and Secondary Primary Cancers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of Secondary Cancers in Pre- vs Post-ICI Eligibility Periods for Metastatic Cancers

Jiyeong Kim, Thet Su Win, Michael L. Chen, Athena Li
JAMA Network Open
Multiple and Secondary Primary Cancers
article

Development of Secondary Cancers in Pre- vs Post-ICI Eligibility Periods for Metastatic Cancers

Jiyeong Kim, Thet Su Win, Michael L. Chen, Athena Li
article en

Abstract

This cohort study investigates incidence of secondary primary cancers before vs after approval of immune checkpoint inhibitors (ICIs) among patients with metastatic cancers.

JAMA Network OpenVol. 9(2)
Brigham and Women's Hospital (US), The University of Texas at Austin (US), Stanford University (US)
Good health and well-being
Openalex Percentile: Top 65%
Multiple and Secondary Primary Cancers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.